Immunological Profiles and prognostic outcomes in patients with alcoholic hepatitis

酒精性肝炎患者的免疫学特征和预后结果

基本信息

项目摘要

Project Summary Alcoholic hepatitis is a leading cause of morbidity and mortality in the US. Despites its complicated pathogenesis, one of the key drivers in the disease process is the alterations in the innate and adaptive immune responses secondary to excessive alcohol use. This application is in response to the funding opportunity “Alcoholic hepatitis clinical and translational network – translational research (RFA-AA-18-003)”. The goal of our application is to better understand the role and mechanism of innate and adaptive immunity in the pathogenesis of alcoholic hepatitis, as this may help us identify novel therapeutic targets to treat this severe form of ALD. Two specific aims are proposed: Aim# 1: Determine the impact and prognostic significance of microbial translocation, immune dysregulation on the disease severity and outcomes in patients with AH. In this aim, we hypothesized that (i) the state of immune dysregulation has the impact on baseline disease severity and long term outcome of patients with AH and (ii) persistent immune activation during the follow up despite abstinence is adversely affected outcomes of patients with AH. We found that ethanol primes peripheral blood mononuclear cells for LPS-induced inflammatory responses. In sub-aim#1.1, we will perform a detail cross sectional/longitudinal analysis on baseline gut permeability, microbial translocation, immune cell activation/inflammation in healthy controls, ED without liver diseases, and those with AH. We also found that plasma IL-8, a potent chemokine for neutrophils, were markedly elevated in patients with AH. The induction of neutrophils leads to hepatic inflammation/injury with the release of mitochrondrial-DNA containing microparticles (MPs) from the hepatocytes; perpetuating neutrophilia and liver injury. In sub-aim#1.2, we will determine the role and clinical significance of IL-8 and mitochrondrial-DNA (mt-DNA) in patients with AH. Aim#2: Determine the mechanism and significance of alteration in follicular helper T cells in patients with AH. Little is known about how alcohol affects the adaptive immune system, despite the increase risk of infections among those with excessive alcohol use. Follicular T helper (TFH) cells are a CD4 T cell lineage uniquely found in the germinal center reaction of secondary lymphoid organs. The specific function of TFH cells is to select B cells in the germinal center that produce high-affinity Abs. Our novel preliminary data showed, for the first time, on the effect of excessive drinking and ALD on circulating TFH (cTFH) cells. In this aim, we hypothesized that excessive alcohol consumption leads to altered cTFH cell differentiation, and that these effects on cTFH cells are augmented and impacted survival outcomes in patients with AH. We will test that (i) AH patients have dysregulation of cTFH cells, (ii) AH patients have T cell-intrinsic or T cell-extrinsic defects that alter cTFH cell differentiation, and, and (iii) AH patients have abnormal B cell responses secondary to dysregulation in cTFH cells. Our results may shed light on the treatment of AH by targeting specific immunological pathways linking to the pathogenesis of AH.
项目总结

项目成果

期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers.
  • DOI:
    10.1016/j.jhep.2021.10.005
  • 发表时间:
    2022-03
  • 期刊:
  • 影响因子:
    25.7
  • 作者:
    Whitfield JB;Schwantes-An TH;Darlay R;Aithal GP;Atkinson SR;Bataller R;Botwin G;Chalasani NP;Cordell HJ;Daly AK;Day CP;Eyer F;Foroud T;Gleeson D;Goldman D;Haber PS;Jacquet JM;Liang T;Liangpunsakul S;Masson S;Mathurin P;Moirand R;McQuillin A;Moreno C;Morgan MY;Mueller S;Müllhaupt B;Nagy LE;Nahon P;Nalpas B;Naveau S;Perney P;Pirmohamed M;Seitz HK;Soyka M;Stickel F;Thompson A;Thursz MR;Trépo E;Morgan TR;Seth D;GenomALC Consortium
  • 通讯作者:
    GenomALC Consortium
Transcriptomic Analysis Reveals the MicroRNAs Responsible for Liver Regeneration Associated With Mortality in Alcohol-Associated Hepatitis.
  • DOI:
    10.1002/hep.31994
  • 发表时间:
    2021-11
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yang Z;Zhang T;Kusumanchi P;Tang Q;Sun Z;Radaeva S;Peiffer B;Shah VH;Kamath P;Gores GJ;Sanyal A;Chalasani N;Jiang Y;Huda N;Ma J;Liangpunsakul S
  • 通讯作者:
    Liangpunsakul S
Interleukin-20 exacerbates acute hepatitis and bacterial infection by downregulating IκBζ target genes in hepatocytes.
  • DOI:
    10.1016/j.jhep.2021.02.004
  • 发表时间:
    2021-07
  • 期刊:
  • 影响因子:
    25.7
  • 作者:
    He Y;Feng D;Hwang S;Mackowiak B;Wang X;Xiang X;Rodrigues RM;Fu Y;Ma J;Ren T;Ait-Ahmed Y;Xu M;Liangpunsakul S;Gao B
  • 通讯作者:
    Gao B
Intestinal dendritic cells, gatekeepers preventing ethanol-induced liver disease.
肠道树突状细胞,预防乙醇引起的肝病的看门人。
  • DOI:
    10.1097/hep.0000000000000236
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Llorente,Cristina;Rungratanawanich,Wiramon;Liangpunsakul,Suthat
  • 通讯作者:
    Liangpunsakul,Suthat
Role of endotoxemia in causing renal dysfunction in cirrhosis.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Suthat Liangpunsakul其他文献

Suthat Liangpunsakul的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Suthat Liangpunsakul', 18)}}的其他基金

FKBP5 in the pathogenesis of alcohol-associated liver disease
FKBP5 在酒精相关性肝病发病机制中的作用
  • 批准号:
    10501012
  • 财政年份:
    2022
  • 资助金额:
    $ 21.15万
  • 项目类别:
FKBP5 in the pathogenesis of alcohol-associated liver disease
FKBP5 在酒精相关性肝病发病机制中的作用
  • 批准号:
    10704686
  • 财政年份:
    2022
  • 资助金额:
    $ 21.15万
  • 项目类别:
S-adenosylmethionine treatment in alcoholic cirrhosis
S-腺苷甲硫氨酸治疗酒精性肝硬化
  • 批准号:
    10022083
  • 财政年份:
    2019
  • 资助金额:
    $ 21.15万
  • 项目类别:
S-adenosylmethionine treatment in alcoholic cirrhosis
S-腺苷甲硫氨酸治疗酒精性肝硬化
  • 批准号:
    10247836
  • 财政年份:
    2019
  • 资助金额:
    $ 21.15万
  • 项目类别:
S-adenosylmethionine treatment in alcoholic cirrhosis
S-腺苷甲硫氨酸治疗酒精性肝硬化
  • 批准号:
    10491274
  • 财政年份:
    2019
  • 资助金额:
    $ 21.15万
  • 项目类别:
Novel animal models to study miRNA-mediated alcoholic liver disease
研究 miRNA 介导的酒精性肝病的新型动物模型
  • 批准号:
    9794130
  • 财政年份:
    2018
  • 资助金额:
    $ 21.15万
  • 项目类别:
Novel animal models to study miRNA-mediated alcoholic liver disease
研究 miRNA 介导的酒精性肝病的新型动物模型
  • 批准号:
    10205559
  • 财政年份:
    2018
  • 资助金额:
    $ 21.15万
  • 项目类别:
Novel animal models to study miRNA-mediated alcoholic liver disease
研究 miRNA 介导的酒精性肝病的新型动物模型
  • 批准号:
    10228102
  • 财政年份:
    2018
  • 资助金额:
    $ 21.15万
  • 项目类别:
Immunological Profiles and prognostic outcomes in patients with alcoholic hepatitis
酒精性肝炎患者的免疫学特征和预后结果
  • 批准号:
    10190739
  • 财政年份:
    2018
  • 资助金额:
    $ 21.15万
  • 项目类别:
Novel animal models to study miRNA-mediated alcoholic liver disease
研究 miRNA 介导的酒精性肝病的新型动物模型
  • 批准号:
    10430148
  • 财政年份:
    2018
  • 资助金额:
    $ 21.15万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.15万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 21.15万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.15万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.15万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.15万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.15万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.15万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 21.15万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 21.15万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 21.15万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了